13F filer · CIK 850529 ↗
Fisher Investments
You are looking at Q1 2026. See the latest, Q2 2026 →
Reported value
$294.89B
+0.6% on the quarter before
Positions
1,016
118 new · 119 sold out
Top 10
33.4%
of the value
Est. gain
−$4.80B
on stocks held all quarter
Est. return
−1.7%
on those stocks since Q4 2025
Positions as of Mar 31, 2026, from Fisher Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 54% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2025. Striped tiles are options.
Largest buys
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Astrazeneca Plc~$2.14BNew · 0.0% → 0.7%+10,845,708 shares
- AbbVie~$1.84BAdded · 0.0% → 0.7%+8,463,716 shares
- Pfizer~$1.49BAdded · 0.4% → 1.0%+53,012,321 shares
- Ishares Tr 7 10yr Tr Bd ETF~$1.17BAdded · 4.4% → 4.8%+12,212,510 shares
- Cisco~$1.10BAdded · 0.1% → 0.5%+14,113,710 shares
- Novartis~$980.6MAdded · 0.4% → 0.7%+6,419,899 shares
- Pbb World Biopharma ETF~$716.7MNew · 0.0% → 0.2%+28,040,859 shares
- Pbb Global Oil Gas Ep ETF~$675.9MNew · 0.0% → 0.2%+19,066,831 shares
- Nvidia~$436.4MAdded · 5.5% → 5.2%+2,502,033 shares
- Pbb Europe Banks ETF~$436.2MNew · 0.0% → 0.1%+15,876,488 shares
Largest sells
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Astrazeneca Plc ADR~$1.99BSold out · 0.7% → 0.0%−21,601,433 shares
- Abbott Laboratories~$1.10BCut · 0.5% → 0.0%−10,688,150 shares
- Adobe~$932.7MCut · 0.5% → 0.0%−3,836,949 shares
- Stryker Corporation~$873.7MCut · 0.4% → 0.1%−2,658,808 shares
- Banco Santander Sa ADR~$646.9MCut · 0.4% → 0.2%−57,347,736 shares
- Ishares Global Energy ETF~$645.5MCut · 0.2% → 0.1%−11,204,783 shares
- Ishares Msci Europe Fn ETF~$587.6MCut · 0.5% → 0.2%−16,860,454 shares
- Boston Scientific~$545.1MCut · 0.3% → 0.0%−8,687,613 shares
- Ishares Global Health Care ETF~$539.9MCut · 0.3% → 0.1%−5,771,341 shares
- Trip Com Group Ltd ADR~$174.8MSold out · 0.1% → 0.0%−2,431,248 shares
Holdings
As of Mar 31, 2026. Changes are in shares against Dec 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NvidiaCOM · shares +2.9% · price −6.5% | 5.2% | $15.44B | −$1.04B | ||||||||
| AppleCOM · shares +2.3% · price −6.6% | 4.9% | $14.32B | −$996.5M | ||||||||
| Ishares Tr 7 10yr Tr Bd ETFCOM · shares +9.1% · price −0.7% | 4.8% | $14.03B | −$97.1M | ||||||||
| AlphabetCOM · shares +2.5% · price −8.1% | 3.8% | $11.23B | −$969.4M | ||||||||
| MicrosoftCOM · shares +2.5% · price −23.5% | 3.3% | $9.60B | −$2.87B | ||||||||
| Vanguard Fds Int Term CorpCOM · shares +6.2% · price −1.2% | 2.5% | $7.38B | −$84.0M | ||||||||
| AmazonCOM · shares +1.8% · price −9.8% | 2.4% | $7.12B | −$757.5M | ||||||||
| Caterpillar Inc.COM · shares +3.0% · price +23.7% | 2.3% | $6.93B | +$1.29B | ||||||||
| TSMCCOM · shares +2.6% · price +11.2% | 2.1% | $6.29B | +$618.1M | ||||||||
| ASMLCOM · shares +2.6% · price +23.5% | 2.1% | $6.08B | +$1.13B | ||||||||
| Goldman SachsCOM · shares +0.8% · price −3.8% | 2.0% | $5.78B | −$223.5M | ||||||||
| ExxonMobilCOM · shares +2.5% · price +41.0% | 1.9% | $5.48B | +$1.55B | ||||||||
| WalmartCOM · shares +0.9% · price +11.6% | 1.7% | $5.09B | +$522.9M | ||||||||
| JPMorgan ChaseCOM · shares +6.3% · price −8.7% | 1.7% | $5.01B | −$449.5M | ||||||||
| BroadcomCOM · shares +6.1% · price −10.6% | 1.5% | $4.55B | −$506.6M | ||||||||
| Chevron CorporationCOM · shares +1.9% · price +35.8% | 1.5% | $4.53B | +$1.17B | ||||||||
| Eli LillyCOM · shares +5.1% · price −14.4% | 1.5% | $4.45B | −$713.6M | ||||||||
| RTXCOM · shares +2.0% · price +5.2% | 1.5% | $4.29B | +$207.1M | ||||||||
| Morgan StanleyCOM · shares +2.3% · price −7.3% | 1.4% | $4.21B | −$324.2M | ||||||||
| CitigroupCOM · shares +3.9% · price −2.8% | 1.4% | $3.99B | −$111.2M | ||||||||
| Freeport-McMoRanCOM · shares +1.9% · price +15.7% | 1.3% | $3.83B | +$510.4M | ||||||||
| MetaCOM · shares +1.1% · price −13.3% | 1.3% | $3.82B | −$581.4M | ||||||||
| Home Depot (The)COM · shares +1.4% · price −4.4% | 1.1% | $3.39B | −$154.4M | ||||||||
| CostcoCOM · shares +1.4% · price +15.5% | 1.1% | $3.21B | +$425.9M | ||||||||
| Merck & Co.COM · shares +6.3% · price +14.3% | 1.1% | $3.18B | +$373.8M | ||||||||
| Total · 1,016 positions | 100% | $294.89B | −$4.80B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2025 to Q1 2026: 897 stocks held throughout, down $4.80B (−1.7%).
- ExxonMobil+$1.55B+41%
- Caterpillar Inc.+$1.29B+24%
- Chevron Corporation+$1.17B+36%
- ASML+$1.13B+23%
- Bp Plc Sponsored ADR ADR+$815.1M+35%
- Alphabet−$969.4M−8%
- Apple−$996.5M−7%
- Nvidia−$1.04B−6%
- SAP−$1.04B−30%
- Microsoft−$2.87B−23%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | $335.83B+14% | SEC ↗ |
| Q1 2026 | May 5, 2026 | $294.89B+1% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 | $292.99B+6% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $276.29B+10% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $251.89B+9% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $231.00B−8% | SEC ↗ |
| Q4 2024 | Feb 5, 2025 | $251.33B+3% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $244.02B+6% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $229.85B+7% | SEC ↗ |
| Q1 2024 | May 9, 2024 | $214.11B+13% | SEC ↗ |
| Q4 2023 | Mar 5, 2024 (amended) | $189.13B+7% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $176.32B−3% | SEC ↗ |
| Q2 2023 | Dec 12, 2023 (amended) | $180.88B+10% | SEC ↗ |
| Q1 2023 | Dec 12, 2023 (amended) | $164.66B+11% | SEC ↗ |
| Q4 2022 | Feb 3, 2023 | $147.93B+11% | SEC ↗ |
| Q3 2022 | Nov 8, 2022 | $133.41B−6% | SEC ↗ |
| Q2 2022 | Aug 9, 2022 | $141.30B−17% | SEC ↗ |
| Q1 2022 | May 5, 2022 | $169.49B−5% | SEC ↗ |
| Q4 2021 | Feb 2, 2022 | $178.57B+11% | SEC ↗ |
| Q3 2021 | Oct 26, 2021 | $161.00B+1% | SEC ↗ |
| Q2 2021 | Jul 27, 2021 | $159.27B+12% | SEC ↗ |
| Q1 2021 | Apr 27, 2021 | $141.96B+6% | SEC ↗ |
| Q4 2020 | Jan 29, 2021 | $133.48B+17% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $114.26B+12% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $102.46B+27% | SEC ↗ |
| Q1 2020 | Apr 28, 2020 | $80.64B−19% | SEC ↗ |
| Q4 2019 | Feb 12, 2020 | $98.96B+9% | SEC ↗ |
| Q3 2019 | Oct 29, 2019 | $91.13B+1% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $90.45B+6% | SEC ↗ |
| Q1 2019 | Apr 22, 2019 (amended) | $85.30B+17% | SEC ↗ |
| Q4 2018 | Jan 25, 2019 | $73.22B−11% | SEC ↗ |
| Q3 2018 | Oct 23, 2018 | $82.37B+7% | SEC ↗ |
| Q2 2018 | Jul 9, 2018 | $77.02B+2% | SEC ↗ |
| Q1 2018 | May 10, 2018 (amended) | $75.40B−2% | SEC ↗ |
| Q4 2017 | Jan 24, 2018 | $76.56B+7% | SEC ↗ |
| Q3 2017 | Oct 17, 2017 | $71.30B+8% | SEC ↗ |
| Q2 2017 | Jul 12, 2017 | $66.32B+6% | SEC ↗ |
| Q1 2017 | Apr 24, 2017 | $62.44B+9% | SEC ↗ |
| Q4 2016 | Jan 10, 2017 | $57.43B+2% | SEC ↗ |
| Q3 2016 | Oct 11, 2016 | $56.32B+4% | SEC ↗ |
| Q2 2016 | Jul 12, 2016 | $53.89B+2% | SEC ↗ |
| Q1 2016 | Apr 15, 2016 | $52.63B | SEC ↗ |